Stefan Oelrich

Stefan Oelrich, Global Head of Pharmaceuticals at Bayer AG, shares insights on the dynamic pharmaceutical landscape. He discusses challenges, such as Europe's struggle with innovation amid rising competition from the US and China, and underscores the need for faster regulations. Oelrich highlights Bayer's focus on new drug launches to counter revenue losses and emphasizes the importance of equitable access to breakthroughs, particularly as they explore cell and gene therapies. His optimism for India's market potential showcases Bayer's strategic partnerships and a tailored approach to local needs.